Organisation involving high tech, life sciences and biotech
Austrianova is one firm that does things that involves high tech, life sciences and biotech. It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science associated business that specialises in the indusion of living cells or bacteria in small casings for protection which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was advanced in Singapore's greatest exploration biotech hub, Biopolis that has global vision in supporting encapsulation facilities like micro encapsulation.
There is a fast growing area of attention in healthy attention and more detailed, in the matter of neutraceuticals which is the understanding and use of probiotic bacteria. Therefore, probiotics encapsulation was developed. The cell-in-a-box technology was developed by Austranova with the aim to guard, cut off, contain and move living cells. This proprietary skill can be used for several reasons and can be used to probiotics, cosmetics and agriculture environmental protection and screening as well as creating the foundation of a controlling investigation device.
In healthcare, this technology helps run harmless attaching of cells or stem cells such as cell therapy, sticking them keep away from the immune system and enabling long period construction of therapeutic molecules in patients. In biotechnology, the cell-in-a-box skill defends cells in bioreactors and fermentors and at the same time, it make easier sanitization of bioproducts produced from the cells and it shorten constructing rate too.
A gigantic ruler cGMP facility for the production of biomedical grade encapsulated cell things was used to effectively constructed and right now, Austrianova is in the journey of building this capability in the whole of SE Asia. This means the use of cell-in-a-box was quite a achievement for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to enable minor quantities of chemotherapy to be used more efficaciously without the usual devastating side outcomes. The encapsulated cell are positioned, using supraselective catheterisation, into blood vessels that drives to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product.
Come to our page for additional details: Stem Cells, Capsules, Encapsulation Technology.
